Tesabio
1 known investors
Tesabio.ai develops an AI platform that identifies small molecules capable of reprogramming disease-specific microRNA (miRNA) networks, aiming to restore balance across biological pathways rather than targeting a single protein or microRNA. The platform is applied to drug discovery for complex diseases such as cancer, neurodegeneration, and immune disorders.
Investors · 1
Frequently asked questions
- What does Tesabio do?
- Tesabio.ai develops an AI platform that identifies small molecules capable of reprogramming disease-specific microRNA (miRNA) networks, aiming to restore balance across biological pathways rather than targeting a single protein or microRNA. The platform is applied to drug discovery for complex diseases such as cancer, neurodegeneration, and immune disorders.
- Who are Tesabio's investors?
- Tesabio's investors include GRIDX.